|Bid||106.10 x 800|
|Ask||118.00 x 1300|
|Day's range||107.60 - 109.70|
|52-week range||52.80 - 121.15|
|PE ratio (TTM)||38.07|
|Earnings date||24 Jul 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||111.67|
ConocoPhillips, Churchill Downs, Wingstop, Usana Health and Marathon Oil are top stocks closing in on buy points from bullish flat bases.
USANA Health Sciences Inc (NYSE:USNA), a personal products company based in United States, saw a significant share price rise of over 20% in the past couple of months on theRead More...
Does the share price for USANA Health Sciences Inc (NYSE:USNA) reflect it’s really worth? Today, I will calculate the stock’s intrinsic value using the discounted cash flow (DCF) method. IfRead More...
NEW YORK, May 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The ...
Herbalife Nutrition (HLF) sustained its growth momentum in 1Q18 and reported strong results. The company’s top line benefited from strong EMEA (Europe, the Middle East, and Africa) and Asia-Pacific market growth, primarily in India and Indonesia. The company returned to growth in its US business, which is a big positive. Going forward, Herbalife’s top line is expected to grow healthily in future quarters, reflecting improved Asia-Pacific and EMEA performance and favorable currency rates. Also, US volumes are expected to improve.
Herbalife Nutrition (HLF) stock has followed a strong uptrend due to improving fundamentals. Herbalife rose ~41% in 2017, and 2018 has turned out to be another great year for the stock, which had risen ~64% YTD (year-to-date) as of May 4. Herbalife reported its 1Q18 results on May 3. Given the strong stock run so far this year, activist investor Bill Ackman, who once called Herbalife a pyramid scheme and betted against the stock, exited his short position against Herbalife.
The Salt Lake City-based company said it had net income of $1.19 per share. The nutritional supplement maker posted revenue of $292 million in the period. USANA Health expects full-year earnings to be ...
Of the analysts covering Herbalife (HLF) stock, 50% of them are recommending a “buy,” and 50% are recommending a “hold.” Herbalife’s sales and profitability were subdued in the first three quarters of 2017. Herbalife’s financials are expected to remain challenged in the near term, given the weakness in its key regions. Currently, analysts have a price target of $86.80 per share for Herbalife stock, which represents an upside of 3.5% compared to its closing price of $83.88 on February 15, 2018.
The Salt Lake City-based company said it had a loss of 24 cents per share. Earnings, adjusted for pretax expenses and non-recurring costs, were $1.11 per share. The nutritional supplement maker posted ...
On a per-share basis, the Salt Lake City-based company said it had profit of 97 cents. Earnings, adjusted for non-recurring costs, were $1.02 per share. The nutritional supplement maker posted revenue ...